Abstract: Central Line-Associated Bloodstream Infection (CLABSI) is a critical aspect of preventing and controlling hospital-acquired infections, as well as improving healthcare quality and patient safety. Investment in the prevention and control of CLABSI can significantly save healthcare resources and improve patient outcomes. This article reviews and summarizes recent national and international health economics research on the prevention and control of CLABSI, with the aim of providing reference and guidance for future studies in this area.

Key words: Central Line-Associated Bloodstream Infection; health economics; economic evaluation